Filing Flows › Intelligent Bio Solutions (INBS) › Q4 FY26
Intelligent Bio Solutions (INBS) Q4 FY26 earnings results (fourth quarter fiscal 2026)
10-K filed Aug 19, 2026
Intelligent Bio Solutions (INBS) reported revenue of $1.1M for the fourth quarter fiscal 2026 (Q4 FY26), +36% from a year earlier and +8% from the quarter before. Operating margin was -346.4%, net loss $3.9M (341.9% of revenue).
Intelligent Bio Solutions, Q4 FY26: revenue $1.1M (+36% year over year), operating margin -346.4%, net loss $3.9M, operating cash flow −$3.2M. The chart follows the revenue to costs, profit and cash.
| Q4 FY26 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.1M | +8% | +36% |
| Operating profit | −$4.0M | — | — |
| Net earnings | −$3.9M | — | — |
| Operating cash flow | −$3.2M | — | — |
What changed
Revenue was $1.1M in Q4 FY26, up 36% year over year and up 8% from the previous quarter. Sales of Goods - Cartidges was the largest line at 55% of revenue.
Gross margin was 46.8%, up 7.1 points from Q4 FY25. Operating costs exceeded revenue by $4.0M, an operating margin of -346.4%. Operating expenses grew 31% against revenue growth of 36%. The fastest-growing cost line was Other operating costs (+111%). The quarter ended with a net loss of $3.9M, wider than the previous quarter's $2.9M loss. Minority interests bore $10K of it: to shareholders the quarter was a loss of $3.9M.
Operating cash flow was −$3.2M. Non-cash charges added back $288K of depreciation and amortization and $97K of share-based compensation. Working capital and other items added $350K.
Questions
What was Intelligent Bio Solutions' revenue in the fourth quarter fiscal 2026?
Intelligent Bio Solutions (INBS) reported revenue of $1.1M for the fourth quarter fiscal 2026 (Q4 FY26), +36% from a year earlier and +8% from the quarter before.
Was Intelligent Bio Solutions profitable in the fourth quarter fiscal 2026?
Operating loss was $4.0M (-346.4% of revenue) and net loss $3.9M.